- Feb 24, 2001
- 17,417
- 3,759
- 113
- School/Org
- University of Michigan Medical School
- City
- Lake Oswego
- State
- OR
Are you interested in adding OCT-Angiography (OCT-A) to your practice?
Do you want to learn the fundamentals of OCT-A?
Dr. Julie Rodman, who published “Optical Coherence Tomography Angiography Atlas: A Case Study Approach”—the first reference book on this topic— joined us for an engaging and insightful webinar designed to introduce the fundamentals of OCT-A.
We explore:
* How OCT-A works and what makes it distinctive
* Key clinical applications and common use cases
* Interpreting OCT-A scans: Identifying normal vs pathological findings
* Practical tips for integrating OCT-A into your clinical workflow
* Why OCT-A metrics are paramount
* Why and how Optovue Solix provides unparallel OCT-A image quality
A live Q&A followed with Dr. Rodman.
About the Speaker
Dr. Julie Rodman is the Chief of the Broward Eye Care Institute in Fort Lauderdale, FL and a Professor of Optometry at Nova Southeastern University.
Her research interests include OCT/OCT-A and Vitreoretinal Disease. Dr. Rodman has authored over thirty publications with an emphasis on retinal disease. She published “Optical Coherence Tomography Angiography Atlas: A Case Study Approach,” the first reference book on this topic written by an optometrist.
Dr. Rodman is a member of the AOA, AAO, FOA, and ORS. She has been the recipient of numerous teaching awards and was recognized as a Primary Care Optometry News “Top 300” Optometrists and “Newsweek Best Optometrists of 2021.”
About Visionix
Visionix is the global manufacturer and exclusive sales, service, and training provider for Optovue OCT, Visionix screening and refraction systems, as well as Briot and Weco lens finishing equipment in North America. We are a pioneer in integrating core refractive, screening, and imaging technologies to address the ever-changing needs of eye care professionals.
Today, we are proud to offer high-speed OCT and OCT-A technology designed to facilitate the diagnosis and management of a range of ocular diseases. Our goal is to improve access to a complete suite of advanced visual health solutions that transform the patient experience.
With over 100 years of innovation, an expanded product line, as well as a new level of support, clinical education, and practice integration, we are well-positioned to help you unlock your potential.
